PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 28115365-0 2017 Activation of PPARgamma by endogenous prostaglandin J2 mediates the antileukemic effect of selenium in murine leukemia. Selenium 91-99 peroxisome proliferator activated receptor gamma Mus musculus 14-23 28115365-4 2017 Here, we show that these endogenous CyPGs, produced by mice maintained on selenium-supplemented diets, alleviate the symptoms of CML through their ability to activate the nuclear hormone receptor, peroxisome proliferator activated receptor gamma (PPARgamma). Selenium 74-82 peroxisome proliferator activated receptor gamma Mus musculus 197-245 28115365-4 2017 Here, we show that these endogenous CyPGs, produced by mice maintained on selenium-supplemented diets, alleviate the symptoms of CML through their ability to activate the nuclear hormone receptor, peroxisome proliferator activated receptor gamma (PPARgamma). Selenium 74-82 peroxisome proliferator activated receptor gamma Mus musculus 247-256 28115365-5 2017 GW9662, a potent PPARgamma antagonist, blocked the antileukemic effect of selenium supplementation by significantly reducing CyPGs. Selenium 74-82 peroxisome proliferator activated receptor gamma Mus musculus 17-26 28115365-6 2017 This effect was mediated by an increase in 15-prostaglandin dehydrogenase (15-Pgdh) activity, which oxidizes and inactivates Delta12-PGJ2 and 15d-PGJ2 In contrast, treatment with the PPARgamma agonist pioglitazone mimicked selenium supplementation. Selenium 223-231 peroxisome proliferator activated receptor gamma Mus musculus 183-192 28115365-8 2017 Selenium-dependent activation of PPARgamma mediated by endogenous CyPGs decreased Stat5 expression leading to the downregulation of Cited2, a master regulator of LSC quiescence. Selenium 0-8 peroxisome proliferator activated receptor gamma Mus musculus 33-42 26644468-9 2016 Antagonism of PPARgamma blocked the effect of selenium. Selenium 46-54 peroxisome proliferator activated receptor gamma Mus musculus 14-23 21775527-9 2011 Furthermore, BMDM treated with inhibitors of PPARgamma and STAT6, pivotal transcription factors that mediate the activity of Se and IL-4, respectively, showed complete ablation of Se-dependent expression of M2 markers. Selenium 125-127 peroxisome proliferator activated receptor gamma Mus musculus 45-54 21775527-10 2011 In summary, these studies suggest that Se supplementation of macrophages produces endogenous activators to mediate the PPARgamma-dependent switch from M1 to M2 phenotype in the presence of IL-4, possibly affecting pathways of wound healing and inflammation resolution. Selenium 39-41 peroxisome proliferator activated receptor gamma Mus musculus 119-128